Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laure Ricard

Showing results (21-30 of 39) with videos related to

Pageof 4
Sort By:
Clinical Hematology International|January 7, 2025
Incidence and impact of other malignancies after immunochemotherapy by fludarabine, cyclophosphamide, and rituximab as frontline treatment for chronic lymphocytic leukemia: A single-center retrospective studyNicolas Stocker, Tamim Alsuliman, Elise Corre, et al.
Bone Marrow Transplantation|April 24, 2020
Autologous hematopoietic stem cell transplantation with reduced-intensity conditioning regimens in refractory Takayasu arteritis: a retrospective multicenter case-series from the Autoimmune Diseases Working Party (ADWP) of the European Society for Blood and Marrow Transplantation (EBMT)Charlotte Laurent, Zora Marjanovic, Laure Ricard, et al.
Haematologica|April 9, 2026
Anti-CD19 CAR T-cell therapy in relapsed/refractory T-cell/histiocyte-rich large B-cell lymphoma: insights from the French DESCAR-T registry, a LYSA studyAxel André, Estelle Bourbon, Guillaume Cartron, et al.
Clinical & Translational Immunology|October 2, 2020
High-dose post-transplant cyclophosphamide impairs γδ T-cell reconstitution after haploidentical haematopoietic stem cell transplantation using low-dose antithymocyte globulin and peripheral blood stem cell graftNicolas Stocker, Béatrice Gaugler, Myriam Labopin, et al.
Journal of Clinical Immunology|June 1, 2024
Unconventional T Cells Influence Clinical Outcome After Allogeneic Hematopoietic Cell TransplantationLama Siblany, Nicolas Stocker, Laure Ricard, et al.
Blood Advances|September 30, 2025
Outcome of patients with mantle cell lymphoma after failure of anti-CD19 CAR T-cell therapy: a DESCAR-T study by LYSA GroupMarion Aymard, Morgane Cheminant, Roch Houot, et al.
RMD Open|March 9, 2023
Identifying high-risk profile in primary antiphospholipid syndrome through cluster analysis: French multicentric cohort studyAlexis F Guedon, Laure Ricard, Charlotte Laurent, et al.
Medicine|July 22, 2016
Digestive-tract sarcoidosis: French nationwide case-control study of 25 casesEtienne Ghrenassia, Arsene Mekinian, Catherine Chapelon-Albric, et al.
Joint Bone Spine|October 17, 2021
Clinical and prognostic significance of antinuclear antibodies in primary antiphospholipid syndrome: A multicenter retrospective studyLaure Ricard, Charlotte Laurent, Matthias Papo, et al.
Arthritis Research & Therapy|January 26, 2022
Non-criteria manifestations in primary antiphospholipid syndrome: a French multicenter retrospective cohort studyAlexis F Guédon, Jennifer Catano, Laure Ricard, et al.
Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
Clinical Hematology International|January 7, 2025
Incidence and impact of other malignancies after immunochemotherapy by fludarabine, cyclophosphamide, and rituximab as frontline treatment for chronic lymphocytic leukemia: A single-center retrospective studyNicolas Stocker, Tamim Alsuliman, Elise Corre, et al.
Bone Marrow Transplantation|April 24, 2020
Autologous hematopoietic stem cell transplantation with reduced-intensity conditioning regimens in refractory Takayasu arteritis: a retrospective multicenter case-series from the Autoimmune Diseases Working Party (ADWP) of the European Society for Blood and Marrow Transplantation (EBMT)Charlotte Laurent, Zora Marjanovic, Laure Ricard, et al.
Haematologica|April 9, 2026
Anti-CD19 CAR T-cell therapy in relapsed/refractory T-cell/histiocyte-rich large B-cell lymphoma: insights from the French DESCAR-T registry, a LYSA studyAxel André, Estelle Bourbon, Guillaume Cartron, et al.
Clinical & Translational Immunology|October 2, 2020
High-dose post-transplant cyclophosphamide impairs γδ T-cell reconstitution after haploidentical haematopoietic stem cell transplantation using low-dose antithymocyte globulin and peripheral blood stem cell graftNicolas Stocker, Béatrice Gaugler, Myriam Labopin, et al.
Journal of Clinical Immunology|June 1, 2024
Unconventional T Cells Influence Clinical Outcome After Allogeneic Hematopoietic Cell TransplantationLama Siblany, Nicolas Stocker, Laure Ricard, et al.
Blood Advances|September 30, 2025
Outcome of patients with mantle cell lymphoma after failure of anti-CD19 CAR T-cell therapy: a DESCAR-T study by LYSA GroupMarion Aymard, Morgane Cheminant, Roch Houot, et al.
RMD Open|March 9, 2023
Identifying high-risk profile in primary antiphospholipid syndrome through cluster analysis: French multicentric cohort studyAlexis F Guedon, Laure Ricard, Charlotte Laurent, et al.
Medicine|July 22, 2016
Digestive-tract sarcoidosis: French nationwide case-control study of 25 casesEtienne Ghrenassia, Arsene Mekinian, Catherine Chapelon-Albric, et al.
Joint Bone Spine|October 17, 2021
Clinical and prognostic significance of antinuclear antibodies in primary antiphospholipid syndrome: A multicenter retrospective studyLaure Ricard, Charlotte Laurent, Matthias Papo, et al.
Arthritis Research & Therapy|January 26, 2022
Non-criteria manifestations in primary antiphospholipid syndrome: a French multicenter retrospective cohort studyAlexis F Guédon, Jennifer Catano, Laure Ricard, et al.
Pageof 4